Physician profile
John Scappaticci
NPI 1063448603
$507.17
in general payments reported to CMS, 2019-2025
14 companies · $16.99 in 2025
The $16.99 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $377 · 2020: $53.52 · 2024: $59.93 · 2025: $16.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $76.92.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $76.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $82.11 | 2019 | |
| Pfizer INC. | $70.24 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $65.38 | 2019 | |
| Novo Nordisk INC | $60.46 | 2019 | |
| Astellas Pharma US INC | $54.29 | 2019-2024 | Veozah |
| Sanofi-Aventis U.S. LLC | $40.16 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $26.08 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $22.98 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.96 | 2019 | |
| Lilly USA, LLC | $14.87 | 2020 | |
| Janssen Pharmaceuticals, INC | $14.38 | 2019 | |
| Amarin Pharma, INC. | $14.35 | 2019 | |
| Amgen INC. | $13.86 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Scappaticci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.